Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€228.50
04.09.24
€277.62
04.09.25
7.26%
14:41

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€185.95
04.09.24
€257.78
04.09.25
-9.60%
14:03

buy
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€29.60
04.09.24
€39.80
04.09.25
5.41%
04.10.24

buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€20.75
03.09.24
€54.39
03.09.25
-16.94%
14:46

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€49.40
03.09.24
€81.54
03.09.25
5.26%
04.10.24

buy
Lexicon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.46
03.09.24
€9.06
03.09.25
4.92%
04.10.24

buy
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€6.60
03.09.24
-
03.09.25
-2.03%
17.09.24

buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€0.74
03.09.24
€51.62
03.09.25
-
26.06.24

buy
Teva Pharmaceutical Industries Ltd ADR

Start price
Target price
Perf. (%)
€16.90
03.09.24
€23.55
03.09.25
-6.51%
14:20

Bayer AG

Start price
Target price
Perf. (%)
€27.77
03.09.24
-
03.10.24
7.15%
04.10.24

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€150.80
03.09.24
€194.53
03.09.25
-3.10%
15:19

Glycomimetics Inc.

Start price
Target price
Perf. (%)
€0.15
03.09.24
-
03.09.25
-7.28%
10:31

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€51.50
03.09.24
€65.15
03.09.25
0.97%
04.10.24

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€871.10
03.09.24
€880.00
03.09.25
-7.70%
03.10.24

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Bayer AG ADR

Start price
Target price
Perf. (%)
€6.90
03.09.24
€7.00
03.09.25
-0.72%
18.09.24

High valuation
Low dividend yield expected
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€867.40
03.09.24
€950.00
03.09.25
-3.39%
14.09.24

buy
Valneva SE

Start price
Target price
Perf. (%)
€3.38
03.09.24
€45.00
03.10.24
-25.15%
04.10.24

buy
Newron Pharmaceut.

Start price
Target price
Perf. (%)
€9.44
02.09.24
-
02.10.24
-9.64%
03.10.24

buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€24.10
02.09.24
-
02.09.25
-20.33%
15.09.24

buy
Evotec SE

Start price
Target price
Perf. (%)
€6.60
02.09.24
€7.00
02.09.25
-7.43%
02.10.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Valuable balance sheet
Cara Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.31
02.09.24
-
02.09.25
-25.39%
09:47

Tonix Pharmaceuticals Holding Corp.

Start price
Target price
Perf. (%)
€2.82
02.09.24
-
02.09.25
-
09.02.24

Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.41
02.09.24
-
02.09.25
-
21.03.24

buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€126.00
02.09.24
€145.50
02.09.25
-1.98%
14.09.24

buy
Valneva SE

Start price
Target price
Perf. (%)
€3.31
02.09.24
-
02.09.25
-13.60%
15.09.24